Pasar al contenido principal

INVESTIGAR EL MECANISMO DE REACTIVACION DE PROMOTORES QUE SE ENCUENTRAN LATENTES EN EL ENDOSPERMO PARA SU USO EN INGENIERIA METABOLICA RESULTANDO EN PLANTAS NO TRANSGENICAS

PGC2018-097655-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE LLEIDA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Inactivation of rice starch branching enzyme IIb triggers broad and unexpected changes in metabolism by transcriptional reprogramming

  • Baysal, Can
  • He, Wenshu
  • Drapal, Margit
  • Villorbina Noguera, Gemma
  • Medina Piles, Vicente
  • Capell Capell, Teresa
  • Khush, Gurdev S.
  • Zhu, Changfu
  • Fraser, Paul
  • Christou, Paul
Starch properties can be modified by mutating genes responsible for the synthesis of amylose and amylopectin in the endosperm. However, little is known about the effects of such targeted modifications on the overall starch biosynthesis pathway and broader metabolism. Here we investigated the effects of mutating the OsSBEIIb gene encoding starch branching enzyme IIb, which is required for amylopectin synthesis in the endosperm. As anticipated, homozygous mutant plants, in which OsSBEIIb was completely inactivated by abolishing the catalytic center and C-terminal regulatory domain, produced opaque seeds with depleted starch reserves. Amylose content in the mutant increased from 19.6 to 27.4% and resistant starch (RS) content increased from 0.2 to 17.2%. Many genes encoding isoforms of AGPase, soluble starch synthase, and other starch branching enzymes were up-regulated, either in their native tissues or in an ectopic manner, whereas genes encoding granule-bound starch synthase, debranching enzymes, pullulanase, and starch phosphorylases were largely down-regulated. There was a general increase in the accumulation of sugars, fatty acids, amino acids, and phytosterols in the mutant endosperm, suggesting that intermediates in the starch biosynthesis pathway increased flux through spillover pathways causing a profound impact on the accumulation of multiple primary and secondary metabolites. Our results provide insights into the broader implications of perturbing starch metabolism in rice endosperm and its impact on the whole plant, which will make it easier to predict the effect of metabolic engineering in cereals for nutritional improvement or the production of valuable metabolites., We would like to acknowledge funding from Ministry of Economy and Competitiveness, Spain (RTI2018-097613-BI00 to C.Z., PGC2018-097655-B-I00 to P.C., and AGL2017-85377-R to T.C.); Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit; and the European Union Framework Program DISCO (from discovery to final products: a next-generation pipeline for the sustainable generation of high-value plant products; Project 613513) to P.D.F.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 2: endemic and re-emerging diseases

  • He, Wenshu
  • Baysal, Can
  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Christou, Paul
  • Oksman-Caldentey, Kirsi-Marja
  • Capell Capell, Teresa
The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, but also by challenges caused by distribution and storage, particularly in regions without a complete cold chain. In this review article, we consider the potential of molecular farming to address the challenges of endemic and re-emerging diseases, focusing on edible plants for the development of oral drugs. Key recent developments in this field include successful clinical trials based on orally delivered dried leaves of Artemisia annua against malarial parasite strains resistant to artemisinin combination therapy, the ability to produce clinical-grade protein drugs in leaves to treat infectious diseases and the long-term storage of protein drugs in dried leaves at ambient temperatures. Recent FDA approval of the first orally delivered protein drug encapsulated in plant cells to treat peanut allergy has opened the door for the development of affordable oral drugs that can be manufactured and distributed in remote areas without cold storage infrastructure and that eliminate the need for expensive purification steps and sterile delivery by injection., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats2017-SGR828); Ag encia de Gesti o d’Ajuts Universitaris i de Recerca (AGAUR), Departament d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020); Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020)—Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT—Biore- sources for Sustainability); UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ. of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana (760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agreement 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A); EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDFnd Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil; BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC; and The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) programme contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Rapid production of SaCas9 in plant-based cell-free lysate for activity testing

  • Schiermeyer, Andreas
  • Cerda‑Bennasser, Pedro
  • Schmelter, Thomas
  • Huang, Xin
  • Christou, Paul
  • Schillberg, Stefan
Cas9 nucleases have become the most versatile tool for genome editing projects in a broad range of organisms. The recombinant production of Cas9 nuclease is desirable for in vitro activity assays or the preparation of ribonucleoproteins (RNPs) for DNAfree genome editing approaches. For the rapid production of Cas9,we explored the use of a recently established cell-free lysate from tobacco (Nicotiana tabacum L.) BY-2 cells. Using this system, the 130-kDaCas9 nuclease from Staphylococcus aureus (SaCas9) was produced and subsequently purified via affinity chromatography. The purified apoenzyme was supplemented with 10 different sgRNAs, and the nuclease activity was confirmed by the linearization of plasmid DNA containing cloned DNA target sequences., We are grateful to Dr. Matthias Buntru (Fraunhofer IME) for providing BY-2 cell lysate and valuable advice on in vitro transcription/ translation. Financial support for this research has been provided by the German Federal Ministry of Education and Research (BMBF, grant number 031B0813) and by the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018-097613-BI00; PGC2018-097655-B-I00); PROSTRIG, ERA-NET Cofund SusCrop (Grant No 771134). AS, PC, and SS conceived the study. AS, PCB, XH, and TS conducted experiments and collected data. AS wrote the manuscript. All authors interpreted the data and proofread and approved the manuscript.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Metabolic engineering of crocin biosynthesis in nicotiana species

  • Ahrazem, Oussama
  • Zhu, Changfu
  • Huang, Xin
  • Rubio-Moraga, Angela
  • Capell Capell, Teresa
  • Christou, Paul
  • Gómez-Gómez, Lourdes
Crocins are high-value soluble pigments that are used as colorants and supplements, their presence in nature is extremely limited and, consequently, the high cost of these metabolites hinders their use by other sectors, such as the pharmaceutical and cosmetic industries. The carotenoid cleavage dioxygenase 2L (CsCCD2L) is the key enzyme in the biosynthetic pathway of crocins in Crocus sativus. In this study, CsCCD2L was introduced into Nicotiana tabacum and Nicotiana glauca for the production of crocins. In addition, a chimeric construct containing the Brevundimonas sp. β-carotene hydroxylase (BrCrtZ), the Arabidopsis thaliana ORANGE mutant gene (AtOrMut), and CsCCD2L was also introduced into N. tabacum. Quantitative and qualitative studies on carotenoids and apocarotenoids in the transgenic plants expressing CsCCD2L alone showed higher crocin level accumulation in N. glauca transgenic plants, reaching almost 400 μg/g DW in leaves, while in N. tabacum 36 μg/g DW was obtained. In contrast, N. tabacum plants coexpressing CsCCD2L, BrCrtZ, and AtOrMut accumulated, 3.5- fold compared to N. tabacum plants only expressing CsCCD2L. Crocins with three and four sugar molecules were the main molecular species in both host systems. Our results demonstrate that the production of saffron apocarotenoids is feasible in engineered Nicotiana species and establishes a basis for the development of strategies that may ultimately lead to the commercial exploitation of these valuable pigments for multiple applications., This study was supported by grants BIO2016-77000-R from the Spanish Ministerio de Ciencia; Innovación y Universidades and SBPLY/17/180501/000234 from the Junta de Comunidades de Castilla-La Mancha (co-financed European Union FEDER funds), the National Natural Science Foundation of China (31870278), the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018-097613-B-I00 and PGC2018-097655-B-I00). CZ and LG-G were participants of the European COST action CA15136 (EUROCAROTEN), and Programa Estatal de Investigación Científica y Técnica de Excelencia, Spain (BIO2015-71703-REDT and BIO2017-90877-REDT).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

The Biosynthesis of Non-Endogenous Apocarotenoids in Transgenic Nicotiana glauca

  • Huang, Xin
  • Morote, Lucía
  • Zhu, Changfu
  • Ahrazem, Oussama
  • Capell Capell, Teresa
  • Christou, Paul
  • Gómez-Gómez, Lourdes
Crocins are high-value compounds with industrial and food applications. Saffron is currently the main source of these soluble pigments, but its high market price hinders its use by sectors, such as pharmaceutics. Enzymes involved in the production of these compounds have been identified in saffron, Buddleja, and gardenia. In this study, the enzyme from Buddleja, BdCCD4.1, was constitutively expressed in Nicotiana glauca, a tobacco species with carotenoid-pigmented petals. The transgenic lines produced significant levels of crocins in their leaves and petals. However, the accumulation of crocins was, in general, higher in the leaves than in the petals, reaching almost 302 µg/g DW. The production of crocins was associated with decreased levels of endogenous carotenoids, mainly β-carotene. The stability of crocins in leaf and petal tissues was evaluated after three years of storage, showing an average reduction of 58.06 ± 2.20% in the petals, and 78.37 ± 5.08% in the leaves. This study illustrates the use of BdCCD4.1 as an effective tool for crocin production in N. glauca and how the tissue has an important impact on the stability of produced high-value metabolites during storage., This work was supported by grants BIO2016-77000-R from the Spanish Ministerio de Ciencia; Innovación y Universidades and SBPLY/17/180501/000234 from the Junta de Comunidades de Castilla-La Mancha (co-financed European Union FEDER funds); the National Natural Science Foundation of China (31870278); and the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018–097613-B-I00; PGC2018–097655-B-I00). C.Z. and L.G.G. are participants of the European COST action CA15136 (EUROCAROTEN) and Programa Estatal de Investigación Científica y Técnica de excelencia, Spain (BIO2015–71703-REDT and BIO2017–90877-REDT).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

The coordinated upregulated expression of genes involved in MEP, chlorophyll, carotenoid and tocopherol pathways, mirrored the corresponding metabolite contents in rice leaves during de-etiolation

  • Jin, Xin
  • Baysal, Can
  • Drapal, Margit
  • Sheng, Yanmin
  • Huang, Xin
  • He, Wenshu
  • Shi, Lianxuan
  • Capell Capell, Teresa
  • Fraser, Paul
  • Christou, Paul
  • Zhu, Changfu
Light is an essential regulator of many developmental processes in higher plants. We investigated the effect of 4-hydroxy-3-methylbut-2-enyl diphosphate reductase 1/2 genes (OsHDR1/2) and isopentenyl diphosphate isomerase 1/2 genes (OsIPPI1/2) on the biosynthesis of chlorophylls, carotenoids, and phytosterols in 14-day-old etiolated rice (Oyza sativa L.) leaves during de-etiolation. However, little is known about the effect of isoprenoid biosynthesis genes on the corresponding metabolites during the de-etiolation of etiolated rice leaves. The results showed that the levels of α-tocopherol were significantly increased in de-etiolated rice leaves. Similar to 1-deoxy-D-xylulose-5-phosphate synthase 3 gene (OsDXS3), both OsDXS1 and OsDXS2 genes encode functional 1-deoxy-D-xylulose-5-phosphate synthase (DXS) activities. Their expression patterns and the synthesis of chlorophyll, carotenoid, and tocopherol metabolites suggested that OsDXS1 is responsible for the biosynthesis of plastidial isoprenoids in de-etiolated rice leaves. The expression analysis of isoprenoid biosynthesis genes revealed that the coordinated expression of the MEP (2-C-methyl-D-erythritol 4-phosphate) pathway, chlorophyll, carotenoid, and tocopherol pathway genes mirrored the changes in the levels of the corresponding metabolites during de-etiolation. The underpinning mechanistic basis of coordinated light-upregulated gene expression was elucidated during the de-etiolation process, specifically the role of light-responsive cis-regulatory motifs in the promoter region of these genes. In silico promoter analysis showed that the light-responsive cis-regulatory elements presented in all the promoter regions of each light-upregulated gene, providing an important link between observed phenotype during de-etiolation and the molecular machinery controlling expression of these genes, This research was funded by Gansu Provincial Key Laboratory of Aridland Crop Science, Gansu Agricultural University (Project No. GSCS-2020-07); The National Natural Science Foundation of China (31870278); the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018-097613-B-I00; PGC2018-097655-B-I00); in part by the European Union Framework Pro- gram DISCO (613513) “from DISCOvery to products: a next-generation pipeline for the sustainable generation of high-value plant products”, the European Cooperation in Science and Technology project EUROCAROTEN (OC-2015-1-19780), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU), and the International Science and Technol- ogy Cooperation Project 20190201013JC (from Jilin Provincial Science and Technology Department, China); GAU-KYQD-2019-06, Gansu Agricultural University.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 1: epidemic and pandemic diseases, including HIV/AIDS and coronaviruses

  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • He, Wenshu
  • Baysal, Can
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Oksman-Caldentey, Kirsi-Marja
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Capell Capell, Teresa
  • Christou, Paul
Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause 17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats 2017-SGR828), Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Departa- ment d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020). Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020 –Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT –Biore- sources for Sustainability). UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana, 760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agree- ment 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF, and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A). EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDF and Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil. BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC. The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Healthand Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) program contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Genome editing in fruit, ornamental, and industrial crops

  • Ramírez Torres, Fabiola G.
  • Ghogare, Rishikesh
  • Stowe, Evan
  • Cerda‑Bennasser, Pedro
  • Lobato, Maria
  • Williamson-Benavides, Bruce A.
  • Girón-Calva, Patricia Sarai
  • Hewitt, Seanna
  • Christou, Paul
  • Dhingra, Amit
The advent of genome editing has opened new avenues for targeted trait enhancement in fruit, ornamental, industrial, and all specialty crops. In particular, CRISPR-based editing systems, derived from bacterial immune systems, have quickly become routinely used tools for research groups across the world seeking to edit plant genomes with a greater level of precision, higher efficiency, reduced off-target effects, and overall ease-of-use compared to ZFNs and TALENs. CRISPR systems have been applied successfully to a number of horticultural and industrial crops to enhance fruit ripening, increase stress tolerance, modify plant architecture, control the timing of flower development, and enhance the accumulation of desired metabolites, among other commercially-important traits. As editing technologies continue to advance, so too does the ability to generate improved crop varieties with non-transgenic modifications; in some crops, direct transgene-free edits have already been achieved, while in others, T-DNAs have successfully been segregated out through crossing. In addition to the potential to produce non-transgenic edited crops, and thereby circumvent regulatory impediments to the release of new, improved crop varieties, targeted gene editing can speed up trait improvement in crops with long juvenile phases, reducing inputs resulting in faster market introduction to the market. While many challenges remain regarding optimization of genome editing in ornamental, fruit, and industrial crops, the ongoing discovery of novel nucleases with niche specialties for engineering applications may form the basis for additional and potentially crop-specific editing strategies., The authors would like to acknowledge funding from MINECO, Spain (PGC2018-097655-B-I00 to P Christou), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU). Work in the Dhingra lab in crop improvement is supported in part by Washington State University Agriculture Research Center Hatch grant WNP00011. ES and FR acknowledge the support received from the Department of Horticulture, BW was supported in part by a Research Assistantship from the Washington State University Graduate School. The authors would also like to thank Drs A. McHughen and H. Quemada for input and clarifications on US genome editing regulations. We would also like to thank the anonymous reviewers for their insightful comments.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Activation of the native PHYTOENE SYNTHASE 1 promoter by modifying near-miss cis‑acting elements induces carotenoid biosynthesis in embryogenic rice callus

  • Sobrino-Mengual, Guillermo
  • Alvarez. Derry
  • Twyman, Richard M.
  • Gerrish, Christopher
  • Fraser, Paul D.
  • Capell Capell, Teresa
  • Christou, Paul
Metabolic engineering in plants typically involves transgene expression or the mutation of endogenous genes. An alternative is promoter modification, where small changes in the promoter sequence allow genes to be switched on or off in particular tissues. To activate silent genes in rice endosperm, we screened native promoters for near-miss cis-acting elements that can be converted to endosperm-active regulatory motifs. We chose rice PHYTOENE SYNTHASE 1 (PSY1), encoding the enzyme responsible for the first committed step in the carotenoid biosynthesis pathway, because it is not expressed in rice endosperm. We identified six motifs within a 120-bp region, upstream of the transcriptional start site, which differed from endosperm-active elements by up to four nucleotides. We mutated four motifs to match functional elements in the endosperm-active BCH2 promoter, and this promoter was able to drive GFP expression in callus and in seeds of regenerated plants. The 4 M promoter was not sufficient to drive PSY1 expression, so we mutated the remaining two elements and used the resulting 6 M promoter to drive PSY1 expression in combination with a PDS transgene. This resulted in deep orange callus tissue indicating the accumulation of carotenoids, which was subsequently confirmed by targeted metabolomics analysis. PSY1 expression driven by the uncorrected or 4 M variants of the promoter plus a PDS transgene produced callus that lacked carotenoids. These results confirm that the adjustment of promoter elements can facilitate the ectopic activation of endogenous plant promoters in rice callus and endosperm and most likely in other tissues and plant species., We acknowledge the Spanish Ministry of Science, Innovation and Universities and the EU (projects RTI2018-097613- B-I00 and PGC2018-097655-B-I00), the Generalitat de Catalunya, AGAUR (Grups Consolidats 2017-SGR828), and Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR). We acknowledge UKRI for funding via the BBSRC-GCRF NUTRIFOOD project. GSM has an FPI fellowship PRE2019-088852.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Genome editing in cereal crops: an overview

  • Matres, Jerlie Mhay
  • Hilscher, Julia
  • Datta, Akash
  • Armario-Nájera, Victoria
  • Baysal, Can
  • He, Wenshu
  • Huang, Xin
  • Zhu, Changfu
  • Valizadeh, R.
  • Trijatmiko, Kurniawan R.
  • Capell Capell, Teresa
  • Christou, Paul
  • Stoger, Eva
  • Slamet-Loedin, Inez H.
Genome-editing technologies offer unprecedented opportunities for crop improvement with superior precision and speed. This review presents an analysis of the current state of genome editing in the major cereal crops- rice, maize, wheat and barley. Genome editing has been used to achieve important agronomic and quality traits in cereals. These include adaptive traits to mitigate the effects of climate change, tolerance to biotic stresses, higher yields, more optimal plant architecture, improved grain quality and nutritional content, and safer products. Not all traits can be achieved through genome editing, and several technical and regulatory challenges need to be overcome for the technology to realize its full potential. Genome editing, however, has already revolutionized cereal crop improvement and is poised to shape future agricultural practices in conjunction with other breeding innovations., The authors would like to acknowledge funding from MINECO, Spain (PGC2018-097655-B-I00 to P Christou), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU), Bill & Melinda Gates Foundation (to I. Slamet-Loedin).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Differential proteomics analysis reveals that Azospirillium brasilense (Sp7) promotes virus tolerance in maize and tomato seedlings

  • Lade, Sarah Boyd
  • Román, Carla
  • Cueto-Ginzo, Ana Isabel
  • Serrano Endolz, Luis
  • Sin Casas, Esther
  • Achón Samá, Mª Ángeles
  • Medina Piles, Vicente
We thank the MINCyT (Spain) for supporting this research with project refs. AGL2010-15691 and PGC2018-097655-B-I00. SL was supported by the UdL-Jade Plus Grant for pre-doctoral researchers and AIC by the UdL-IMPULS program. The authors would like to especially thank Dr. Isabel Sanchez for helping with the proteomic analysis., Plant growth-promoting rhizobacteria such as Azospirillum brasilense Sp7 can protect plants against viruses but the molecular basis of this phenomenon is unclear. We therefore used differential proteomics to study two pathosystems in the presence and absence of Sp7 during early vegetative growth: tomato (Solanum lycopersicum L. cv. Boludo)/Potato virus X (PVX, KJ631111)/Sp7, and maize (Zea mays cv. B73)/Maize dwarf mosaic virus (MDMV, AM110558)/Sp7). In the maize/MDMV system, PDQuest revealed significant variations in the levels of 19 proteins compared to uninfected controls, including the upregulation of NADP-dependent malic enzyme as a form of host-specific viral anticipation, causing a simultaneous increase in the abundance of proteins related to photosynthesis and plastid functions. However, 42 proteins varied significantly in the maize/MDMV/Sp7 system, including the upregulation of radical-scavenging enzymes and proteins related to methionine metabolism, the glutathione-ascorbate cycle and photosynthesis, increasing the photosynthetic rate. In the tomato/PVX system, we observed significant variations in the levels of 58 proteins reflecting the disruption of the Calvin-Benson cycle, responses to oxidative stress and the inhibition of photosystem II (PSII) activity. We identified 26 proteins that varied in the tomato/PVX/Sp7 system; PSII and plastid proteins transiently declined but partially recovered over time as the Calvin-Benson cycle was induced to compensate. Sp7 therefore triggers induced systemic resistance in both pathosystems without affecting the virus titer, although it does delay the appearance of MDMV. The role of ribulose-1.5-bisphosphate carboxylase/oxygenase small subunit as a host target for viruses is discussed in both pathosystems.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities

  • Lobato, Maria
  • Hewitt, Seanna
  • Capell Capell, Teresa
  • Christou, Paul
  • Dhingra, Amit
  • Girón-Calva, Patricia Sarai
Breeding has been used successfully for many years in the fruit industry, giving rise to most of today's commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction of such novel fruits has been slow and limited with only five genetically engineered fruits currently produced as commercial varieties virus-resistant papaya and squash were commercialized 25 years ago, whereas insect-resistant eggplant, non-browning apple, and pink-fleshed pineapple have been approved for commercialization within the last 6 years and production continues to increase every year. Advances in molecular genetics, particularly the new wave of genome editing technologies, provide opportunities to develop new fruit cultivars more rapidly. Our review, emphasizes the socioeconomic impact of current commercial fruit cultivars developed by genetic engineering and the potential impact of genome editing on the development of improved cultivars at an accelerated rate., M.L.-G., P.S.G.-C., P.C., and T.C. would like to acknowledge funding from MINECO, Spain (PGC2018-097655-B-I00 to P Christou), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU). P.S.G.-C. was supported through an Agrotecnio postdoctoral fellowship. A.D. acknowledges the support from Washington State University Agriculture Center Research Hatch grant WNP00011.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 2: endemic and re-emerging diseases

  • He, Wenshu
  • Baysal, Can
  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Christou, Paul
  • Oksman-Caldentey, Kirsi-Marja
  • Capell Capell, Teresa
The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, but also by challenges caused by distribution and storage, particularly in regions without a complete cold chain. In this review article, we consider the potential of molecular farming to address the challenges of endemic and re-emerging diseases, focusing on edible plants for the development of oral drugs. Key recent developments in this field include successful clinical trials based on orally delivered dried leaves of Artemisia annua against malarial parasite strains resistant to artemisinin combination therapy, the ability to produce clinical-grade protein drugs in leaves to treat infectious diseases and the long-term storage of protein drugs in dried leaves at ambient temperatures. Recent FDA approval of the first orally delivered protein drug encapsulated in plant cells to treat peanut allergy has opened the door for the development of affordable oral drugs that can be manufactured and distributed in remote areas without cold storage infrastructure and that eliminate the need for expensive purification steps and sterile delivery by injection., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats2017-SGR828); Ag encia de Gesti o d’Ajuts Universitaris i de Recerca (AGAUR), Departament d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020); Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020)—Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT—Biore- sources for Sustainability); UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ. of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana (760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agreement 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A); EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDFnd Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil; BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC; and The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) programme contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Rapid production of SaCas9 in plant-based cell-free lysate for activity testing

  • Schiermeyer, Andreas
  • Cerda‑Bennasser, Pedro
  • Schmelter, Thomas
  • Huang, Xin
  • Christou, Paul
  • Schillberg, Stefan
Cas9 nucleases have become the most versatile tool for genome editing projects in a broad range of organisms. The recombinant production of Cas9 nuclease is desirable for in vitro activity assays or the preparation of ribonucleoproteins (RNPs) for DNAfree genome editing approaches. For the rapid production of Cas9,we explored the use of a recently established cell-free lysate from tobacco (Nicotiana tabacum L.) BY-2 cells. Using this system, the 130-kDaCas9 nuclease from Staphylococcus aureus (SaCas9) was produced and subsequently purified via affinity chromatography. The purified apoenzyme was supplemented with 10 different sgRNAs, and the nuclease activity was confirmed by the linearization of plasmid DNA containing cloned DNA target sequences., We are grateful to Dr. Matthias Buntru (Fraunhofer IME) for providing BY-2 cell lysate and valuable advice on in vitro transcription/ translation. Financial support for this research has been provided by the German Federal Ministry of Education and Research (BMBF, grant number 031B0813) and by the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018-097613-BI00; PGC2018-097655-B-I00); PROSTRIG, ERA-NET Cofund SusCrop (Grant No 771134). AS, PC, and SS conceived the study. AS, PCB, XH, and TS conducted experiments and collected data. AS wrote the manuscript. All authors interpreted the data and proofread and approved the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 1: epidemic and pandemic diseases, including HIV/AIDS and coronaviruses

  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • He, Wenshu
  • Baysal, Can
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Oksman-Caldentey, Kirsi-Marja
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Capell Capell, Teresa
  • Christou, Paul
Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause 17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats 2017-SGR828), Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Departa- ment d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020). Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020 –Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT –Biore- sources for Sustainability). UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana, 760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agree- ment 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF, and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A). EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDF and Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil. BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC. The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Healthand Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) program contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Differential proteomics analysis reveals that Azospirillium brasilense (Sp7) promotes virus tolerance in maize and tomato seedlings

  • Lade, Sarah Boyd
  • Román, Carla
  • Cueto-Ginzo, Ana Isabel
  • Serrano Endolz, Luis
  • Sin Casas, Esther
  • Achón Samá, Mª Ángeles
  • Medina Piles, Vicente
We thank the MINCyT (Spain) for supporting this research with project refs. AGL2010-15691 and PGC2018-097655-B-I00. SL was supported by the UdL-Jade Plus Grant for pre-doctoral researchers and AIC by the UdL-IMPULS program. The authors would like to especially thank Dr. Isabel Sanchez for helping with the proteomic analysis., Plant growth-promoting rhizobacteria such as Azospirillum brasilense Sp7 can protect plants against viruses but the molecular basis of this phenomenon is unclear. We therefore used differential proteomics to study two pathosystems in the presence and absence of Sp7 during early vegetative growth: tomato (Solanum lycopersicum L. cv. Boludo)/Potato virus X (PVX, KJ631111)/Sp7, and maize (Zea mays cv. B73)/Maize dwarf mosaic virus (MDMV, AM110558)/Sp7). In the maize/MDMV system, PDQuest revealed significant variations in the levels of 19 proteins compared to uninfected controls, including the upregulation of NADP-dependent malic enzyme as a form of host-specific viral anticipation, causing a simultaneous increase in the abundance of proteins related to photosynthesis and plastid functions. However, 42 proteins varied significantly in the maize/MDMV/Sp7 system, including the upregulation of radical-scavenging enzymes and proteins related to methionine metabolism, the glutathione-ascorbate cycle and photosynthesis, increasing the photosynthetic rate. In the tomato/PVX system, we observed significant variations in the levels of 58 proteins reflecting the disruption of the Calvin-Benson cycle, responses to oxidative stress and the inhibition of photosystem II (PSII) activity. We identified 26 proteins that varied in the tomato/PVX/Sp7 system; PSII and plastid proteins transiently declined but partially recovered over time as the Calvin-Benson cycle was induced to compensate. Sp7 therefore triggers induced systemic resistance in both pathosystems without affecting the virus titer, although it does delay the appearance of MDMV. The role of ribulose-1.5-bisphosphate carboxylase/oxygenase small subunit as a host target for viruses is discussed in both pathosystems.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities

  • Lobato, Maria
  • Hewitt, Seanna
  • Capell Capell, Teresa
  • Christou, Paul
  • Dhingra, Amit
  • Girón-Calva, Patricia Sarai
Breeding has been used successfully for many years in the fruit industry, giving rise to most of today's commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction of such novel fruits has been slow and limited with only five genetically engineered fruits currently produced as commercial varieties virus-resistant papaya and squash were commercialized 25 years ago, whereas insect-resistant eggplant, non-browning apple, and pink-fleshed pineapple have been approved for commercialization within the last 6 years and production continues to increase every year. Advances in molecular genetics, particularly the new wave of genome editing technologies, provide opportunities to develop new fruit cultivars more rapidly. Our review, emphasizes the socioeconomic impact of current commercial fruit cultivars developed by genetic engineering and the potential impact of genome editing on the development of improved cultivars at an accelerated rate., M.L.-G., P.S.G.-C., P.C., and T.C. would like to acknowledge funding from MINECO, Spain (PGC2018-097655-B-I00 to P Christou), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU). P.S.G.-C. was supported through an Agrotecnio postdoctoral fellowship. A.D. acknowledges the support from Washington State University Agriculture Center Research Hatch grant WNP00011.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The coordinated upregulated expression of genes involved in MEP, chlorophyll, carotenoid and tocopherol pathways, mirrored the corresponding metabolite contents in rice leaves during de-etiolation

  • Jin, Xin
  • Baysal, Can
  • Drapal, Margit
  • Sheng, Yanmin
  • Huang, Xin
  • He, Wenshu
  • Shi, Lianxuan
  • Capell Capell, Teresa
  • Fraser, Paul
  • Christou, Paul
  • Zhu, Changfu
Light is an essential regulator of many developmental processes in higher plants. We investigated the effect of 4-hydroxy-3-methylbut-2-enyl diphosphate reductase 1/2 genes (OsHDR1/2) and isopentenyl diphosphate isomerase 1/2 genes (OsIPPI1/2) on the biosynthesis of chlorophylls, carotenoids, and phytosterols in 14-day-old etiolated rice (Oyza sativa L.) leaves during de-etiolation. However, little is known about the effect of isoprenoid biosynthesis genes on the corresponding metabolites during the de-etiolation of etiolated rice leaves. The results showed that the levels of α-tocopherol were significantly increased in de-etiolated rice leaves. Similar to 1-deoxy-D-xylulose-5-phosphate synthase 3 gene (OsDXS3), both OsDXS1 and OsDXS2 genes encode functional 1-deoxy-D-xylulose-5-phosphate synthase (DXS) activities. Their expression patterns and the synthesis of chlorophyll, carotenoid, and tocopherol metabolites suggested that OsDXS1 is responsible for the biosynthesis of plastidial isoprenoids in de-etiolated rice leaves. The expression analysis of isoprenoid biosynthesis genes revealed that the coordinated expression of the MEP (2-C-methyl-D-erythritol 4-phosphate) pathway, chlorophyll, carotenoid, and tocopherol pathway genes mirrored the changes in the levels of the corresponding metabolites during de-etiolation. The underpinning mechanistic basis of coordinated light-upregulated gene expression was elucidated during the de-etiolation process, specifically the role of light-responsive cis-regulatory motifs in the promoter region of these genes. In silico promoter analysis showed that the light-responsive cis-regulatory elements presented in all the promoter regions of each light-upregulated gene, providing an important link between observed phenotype during de-etiolation and the molecular machinery controlling expression of these genes, This research was funded by Gansu Provincial Key Laboratory of Aridland Crop Science, Gansu Agricultural University (Project No. GSCS-2020-07); The National Natural Science Foundation of China (31870278); the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018-097613-B-I00; PGC2018-097655-B-I00); in part by the European Union Framework Pro- gram DISCO (613513) “from DISCOvery to products: a next-generation pipeline for the sustainable generation of high-value plant products”, the European Cooperation in Science and Technology project EUROCAROTEN (OC-2015-1-19780), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU), and the International Science and Technol- ogy Cooperation Project 20190201013JC (from Jilin Provincial Science and Technology Department, China); GAU-KYQD-2019-06, Gansu Agricultural University.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Inactivation of rice starch branching enzyme IIb triggers broad and unexpected changes in metabolism by transcriptional reprogramming

  • Baysal, Can
  • He, Wenshu
  • Drapal, Margit
  • Villorbina Noguera, Gemma
  • Medina Piles, Vicente
  • Capell Capell, Teresa
  • Khush, Gurdev S.
  • Zhu, Changfu
  • Fraser, Paul
  • Christou, Paul
Starch properties can be modified by mutating genes responsible for the synthesis of amylose and amylopectin in the endosperm. However, little is known about the effects of such targeted modifications on the overall starch biosynthesis pathway and broader metabolism. Here we investigated the effects of mutating the OsSBEIIb gene encoding starch branching enzyme IIb, which is required for amylopectin synthesis in the endosperm. As anticipated, homozygous mutant plants, in which OsSBEIIb was completely inactivated by abolishing the catalytic center and C-terminal regulatory domain, produced opaque seeds with depleted starch reserves. Amylose content in the mutant increased from 19.6 to 27.4% and resistant starch (RS) content increased from 0.2 to 17.2%. Many genes encoding isoforms of AGPase, soluble starch synthase, and other starch branching enzymes were up-regulated, either in their native tissues or in an ectopic manner, whereas genes encoding granule-bound starch synthase, debranching enzymes, pullulanase, and starch phosphorylases were largely down-regulated. There was a general increase in the accumulation of sugars, fatty acids, amino acids, and phytosterols in the mutant endosperm, suggesting that intermediates in the starch biosynthesis pathway increased flux through spillover pathways causing a profound impact on the accumulation of multiple primary and secondary metabolites. Our results provide insights into the broader implications of perturbing starch metabolism in rice endosperm and its impact on the whole plant, which will make it easier to predict the effect of metabolic engineering in cereals for nutritional improvement or the production of valuable metabolites., We would like to acknowledge funding from Ministry of Economy and Competitiveness, Spain (RTI2018-097613-BI00 to C.Z., PGC2018-097655-B-I00 to P.C., and AGL2017-85377-R to T.C.); Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit; and the European Union Framework Program DISCO (from discovery to final products: a next-generation pipeline for the sustainable generation of high-value plant products; Project 613513) to P.D.F.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The Biosynthesis of Non-Endogenous Apocarotenoids in Transgenic Nicotiana glauca

  • Huang, Xin
  • Morote, Lucía
  • Zhu, Changfu
  • Ahrazem, Oussama
  • Capell Capell, Teresa
  • Christou, Paul
  • Gómez-Gómez, Lourdes
Crocins are high-value compounds with industrial and food applications. Saffron is currently the main source of these soluble pigments, but its high market price hinders its use by sectors, such as pharmaceutics. Enzymes involved in the production of these compounds have been identified in saffron, Buddleja, and gardenia. In this study, the enzyme from Buddleja, BdCCD4.1, was constitutively expressed in Nicotiana glauca, a tobacco species with carotenoid-pigmented petals. The transgenic lines produced significant levels of crocins in their leaves and petals. However, the accumulation of crocins was, in general, higher in the leaves than in the petals, reaching almost 302 µg/g DW. The production of crocins was associated with decreased levels of endogenous carotenoids, mainly β-carotene. The stability of crocins in leaf and petal tissues was evaluated after three years of storage, showing an average reduction of 58.06 ± 2.20% in the petals, and 78.37 ± 5.08% in the leaves. This study illustrates the use of BdCCD4.1 as an effective tool for crocin production in N. glauca and how the tissue has an important impact on the stability of produced high-value metabolites during storage., This work was supported by grants BIO2016-77000-R from the Spanish Ministerio de Ciencia; Innovación y Universidades and SBPLY/17/180501/000234 from the Junta de Comunidades de Castilla-La Mancha (co-financed European Union FEDER funds); the National Natural Science Foundation of China (31870278); and the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018–097613-B-I00; PGC2018–097655-B-I00). C.Z. and L.G.G. are participants of the European COST action CA15136 (EUROCAROTEN) and Programa Estatal de Investigación Científica y Técnica de excelencia, Spain (BIO2015–71703-REDT and BIO2017–90877-REDT).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genome editing in cereal crops: an overview

  • Matres, Jerlie Mhay
  • Hilscher, Julia
  • Datta, Akash
  • Armario-Nájera, Victoria
  • Baysal, Can
  • He, Wenshu
  • Huang, Xin
  • Zhu, Changfu
  • Valizadeh, R.
  • Trijatmiko, Kurniawan R.
  • Capell Capell, Teresa
  • Christou, Paul
  • Stoger, Eva
  • Slamet-Loedin, Inez H.
Genome-editing technologies offer unprecedented opportunities for crop improvement with superior precision and speed. This review presents an analysis of the current state of genome editing in the major cereal crops- rice, maize, wheat and barley. Genome editing has been used to achieve important agronomic and quality traits in cereals. These include adaptive traits to mitigate the effects of climate change, tolerance to biotic stresses, higher yields, more optimal plant architecture, improved grain quality and nutritional content, and safer products. Not all traits can be achieved through genome editing, and several technical and regulatory challenges need to be overcome for the technology to realize its full potential. Genome editing, however, has already revolutionized cereal crop improvement and is poised to shape future agricultural practices in conjunction with other breeding innovations., The authors would like to acknowledge funding from MINECO, Spain (PGC2018-097655-B-I00 to P Christou), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU), Bill & Melinda Gates Foundation (to I. Slamet-Loedin).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genome editing in fruit, ornamental, and industrial crops

  • Ramírez Torres, Fabiola G.
  • Ghogare, Rishikesh
  • Stowe, Evan
  • Cerda‑Bennasser, Pedro
  • Lobato, Maria
  • Williamson-Benavides, Bruce A.
  • Girón-Calva, Patricia Sarai
  • Hewitt, Seanna
  • Christou, Paul
  • Dhingra, Amit
The advent of genome editing has opened new avenues for targeted trait enhancement in fruit, ornamental, industrial, and all specialty crops. In particular, CRISPR-based editing systems, derived from bacterial immune systems, have quickly become routinely used tools for research groups across the world seeking to edit plant genomes with a greater level of precision, higher efficiency, reduced off-target effects, and overall ease-of-use compared to ZFNs and TALENs. CRISPR systems have been applied successfully to a number of horticultural and industrial crops to enhance fruit ripening, increase stress tolerance, modify plant architecture, control the timing of flower development, and enhance the accumulation of desired metabolites, among other commercially-important traits. As editing technologies continue to advance, so too does the ability to generate improved crop varieties with non-transgenic modifications; in some crops, direct transgene-free edits have already been achieved, while in others, T-DNAs have successfully been segregated out through crossing. In addition to the potential to produce non-transgenic edited crops, and thereby circumvent regulatory impediments to the release of new, improved crop varieties, targeted gene editing can speed up trait improvement in crops with long juvenile phases, reducing inputs resulting in faster market introduction to the market. While many challenges remain regarding optimization of genome editing in ornamental, fruit, and industrial crops, the ongoing discovery of novel nucleases with niche specialties for engineering applications may form the basis for additional and potentially crop-specific editing strategies., The authors would like to acknowledge funding from MINECO, Spain (PGC2018-097655-B-I00 to P Christou), Generalitat de Catalunya Grant 2017 SGR 828 to the Agricultural Biotechnology and Bioeconomy Unit (ABBU). Work in the Dhingra lab in crop improvement is supported in part by Washington State University Agriculture Research Center Hatch grant WNP00011. ES and FR acknowledge the support received from the Department of Horticulture, BW was supported in part by a Research Assistantship from the Washington State University Graduate School. The authors would also like to thank Drs A. McHughen and H. Quemada for input and clarifications on US genome editing regulations. We would also like to thank the anonymous reviewers for their insightful comments.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Activation of the native PHYTOENE SYNTHASE 1 promoter by modifying near-miss cis‑acting elements induces carotenoid biosynthesis in embryogenic rice callus

  • Sobrino-Mengual, Guillermo
  • Alvarez. Derry
  • Twyman, Richard M.
  • Gerrish, Christopher
  • Fraser, Paul D.
  • Capell Capell, Teresa
  • Christou, Paul
Metabolic engineering in plants typically involves transgene expression or the mutation of endogenous genes. An alternative is promoter modification, where small changes in the promoter sequence allow genes to be switched on or off in particular tissues. To activate silent genes in rice endosperm, we screened native promoters for near-miss cis-acting elements that can be converted to endosperm-active regulatory motifs. We chose rice PHYTOENE SYNTHASE 1 (PSY1), encoding the enzyme responsible for the first committed step in the carotenoid biosynthesis pathway, because it is not expressed in rice endosperm. We identified six motifs within a 120-bp region, upstream of the transcriptional start site, which differed from endosperm-active elements by up to four nucleotides. We mutated four motifs to match functional elements in the endosperm-active BCH2 promoter, and this promoter was able to drive GFP expression in callus and in seeds of regenerated plants. The 4 M promoter was not sufficient to drive PSY1 expression, so we mutated the remaining two elements and used the resulting 6 M promoter to drive PSY1 expression in combination with a PDS transgene. This resulted in deep orange callus tissue indicating the accumulation of carotenoids, which was subsequently confirmed by targeted metabolomics analysis. PSY1 expression driven by the uncorrected or 4 M variants of the promoter plus a PDS transgene produced callus that lacked carotenoids. These results confirm that the adjustment of promoter elements can facilitate the ectopic activation of endogenous plant promoters in rice callus and endosperm and most likely in other tissues and plant species., We acknowledge the Spanish Ministry of Science, Innovation and Universities and the EU (projects RTI2018-097613- B-I00 and PGC2018-097655-B-I00), the Generalitat de Catalunya, AGAUR (Grups Consolidats 2017-SGR828), and Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR). We acknowledge UKRI for funding via the BBSRC-GCRF NUTRIFOOD project. GSM has an FPI fellowship PRE2019-088852.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metabolic engineering of crocin biosynthesis in nicotiana species

  • Ahrazem, Oussama
  • Zhu, Changfu
  • Huang, Xin
  • Rubio-Moraga, Angela
  • Capell Capell, Teresa
  • Christou, Paul
  • Gómez-Gómez, Lourdes
Crocins are high-value soluble pigments that are used as colorants and supplements, their presence in nature is extremely limited and, consequently, the high cost of these metabolites hinders their use by other sectors, such as the pharmaceutical and cosmetic industries. The carotenoid cleavage dioxygenase 2L (CsCCD2L) is the key enzyme in the biosynthetic pathway of crocins in Crocus sativus. In this study, CsCCD2L was introduced into Nicotiana tabacum and Nicotiana glauca for the production of crocins. In addition, a chimeric construct containing the Brevundimonas sp. β-carotene hydroxylase (BrCrtZ), the Arabidopsis thaliana ORANGE mutant gene (AtOrMut), and CsCCD2L was also introduced into N. tabacum. Quantitative and qualitative studies on carotenoids and apocarotenoids in the transgenic plants expressing CsCCD2L alone showed higher crocin level accumulation in N. glauca transgenic plants, reaching almost 400 μg/g DW in leaves, while in N. tabacum 36 μg/g DW was obtained. In contrast, N. tabacum plants coexpressing CsCCD2L, BrCrtZ, and AtOrMut accumulated, 3.5- fold compared to N. tabacum plants only expressing CsCCD2L. Crocins with three and four sugar molecules were the main molecular species in both host systems. Our results demonstrate that the production of saffron apocarotenoids is feasible in engineered Nicotiana species and establishes a basis for the development of strategies that may ultimately lead to the commercial exploitation of these valuable pigments for multiple applications., This study was supported by grants BIO2016-77000-R from the Spanish Ministerio de Ciencia; Innovación y Universidades and SBPLY/17/180501/000234 from the Junta de Comunidades de Castilla-La Mancha (co-financed European Union FEDER funds), the National Natural Science Foundation of China (31870278), the Spanish Ministry of Economy and Competitiveness (MINECO), Spain (RTI2018-097613-B-I00 and PGC2018-097655-B-I00). CZ and LG-G were participants of the European COST action CA15136 (EUROCAROTEN), and Programa Estatal de Investigación Científica y Técnica de Excelencia, Spain (BIO2015-71703-REDT and BIO2017-90877-REDT).